Position in JNJ
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$7,318,653
+$299,314 QoQ
Shares Held
28,817
+0.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.50%
of 13F equity value
Holder Rank
#1,311
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MARCO INVESTMENT MANAGEMENT LLC holds $82,947,226 across 10 Drug Manufacturers - General names. JNJ ranks #4 (8.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
139,569 | $35,121,143 | |
| 2 | AMGN |
Amgen Inc
|
43,180 | $15,636,341 | |
| 3 | MRK |
Merck & Co., Inc.
|
95,255 | $12,240,267 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
28,817 | $7,318,653 | |
| 5 | PFE |
Pfizer Inc
|
134,025 | $3,227,322 | |
| 6 | LLY |
ELI LILLY & Co
|
2,149 | $2,577,575 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
19,101 | $2,413,220 | |
| 8 | NVS |
Novartis AG
|
13,875 | $2,174,490 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,318,653 | 28,817 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $7,019,339 | 28,716 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $5,927,048 | 28,640 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $5,277,794 | 28,464 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $4,308,924 | 28,209 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $4,686,472 | 28,259 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $4,108,364 | 28,408 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $4,700,874 | 29,007 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $4,253,840 | 29,104 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $4,575,329 | 28,923 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $4,631,353 | 29,548 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $4,975,745 | 31,947 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $5,343,813 | 32,285 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $5,187,385 | 33,467 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $5,882,621 | 33,301 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $5,472,233 | 33,498 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,950,312 | 33,521 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $5,941,990 | 33,527 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $5,723,660 | 33,458 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $5,290,255 | 32,757 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $5,407,096 | 32,822 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $5,398,240 | 32,846 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $4,848,877 | 30,810 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $4,497,515 | 30,209 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $4,062,800 | 28,890 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $3,691,047 | 28,148 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||